Cost-effectiveness study of oral hypoglycemic agents in the treatment of outpatients with type 2 diabetes attending a public primary care clinic in Mexico City

References

• González-VillalpandoCLópez-RidauraRCampuzanoJCGonzález-VillalpandoMEThe status of diabetes care in Mexican population: Are we making a difference? Results of the National Health and Nutrition Survey 2006Salud Publica Mex201052 Suppl 13646
   Web of Science ®Google Scholar
• SimpsonSHCorabianPJacobsPJohnsonJAThe cost of major comorbidity in people with diabetes mellitusCMAJ2003168131661166712821619
   PubMed Web of Science ®Google Scholar
• BarcelóAAedoCRjpathakSRoblesSThe cost of diabetes in Latin America and the CaribbeanBull World Health Organ2003811192712640472
   PubMed Web of Science ®Google Scholar
• International Diabetes Federation Available from http://www.idf.org/Accessed May 12, 2011
   Google Scholar
• International Diabetes Federation (IDF)Prevalence estimates of diabetes mellitus2010 Available from: http://www.diabetesatlas.org/downloadsAccessed February 24, 2011
   Google Scholar
• RullJAAguilar-SalinasCARojasRRíos-TorresJMGómez-PerezFJOlaizGEpidemiology of type 2 diabetes in MexicoArch Med Res200536318819615925009
   PubMed Web of Science ®Google Scholar
• Córdova-VillalobosJABarriguete-MeléndezJALara-EsquedaAChronic non-communicable diseases in Mexico: epidemiologic synopsis and integral preventionSalud Publica Mex200850541942718852939
   PubMed Web of Science ®Google Scholar
• Instituto Nacional de Estadística, Geografía e Historia (INEGI)Principales causas de defunción en México en el ano 2008Principal reasons of death in Mexico in 20082010 Available from: http://www.inegi.org.mx/Sistemas/temasV2/Default.aspx?s=est&c=17484Accessed April 30, 2010
   Google Scholar
• ArredondoAde IcazaEFinancial requirements for the treatment of diabetes in Latin America: implications for the health system and for patients in MexicoDiabetologia20095281693169519504083
   PubMed Web of Science ®Google Scholar
• ArredondoAZúñigaAEconomic consequences of epidemiological changes in diabetes in middle-income countries: the Mexican caseDiabetes Care200427110410914693974
   PubMed Web of Science ®Google Scholar
• Consejo de Salubridad GeneralEdición 2008 del Cuadro Básico y Catálogo de Medicamentos (CByCM). Diario Oficial de la Federación (DOF). 25 de marzo del 2009. Tercera y Cuarta sección2008 edition of the Drug Essential List (CByCM). Federal Official Daily Gazette (DOF). March 25, 2009. Third and Fourth section Spanish
   Google Scholar
• Consejo de Salubridad GeneralPrimera actualización de la Edición 2008 del Cuadro Básico y Catálogo de Medicamentos. Diario Oficial de la Federación (DOF). 08 de abril del 2009. Tercera secciónFirst update of 2008 edition of the Essential Drug List (CByCM). Federal Official Daily Gazette (DOF). April 8, 2009. Third section Available from: http://www.ordenjuridico.gob.mx/Federal/PE/APF/APC/SSA/Aclaraciones/2009/08042009%281%29.pdfAccessed December 6, 2011 Spanish
   Google Scholar
• MueningPDesigning and Conducting Cost-Effectiveness Analyses in Medicine and Health CareSan Francisco, CAJossey-Bass2002
   Google Scholar
• Secretaría de SaludModificación a la Norma Oficial Mexicana NOM-015-SSA2-1994, Para la prevención, tratamiento y control de la diabetes mellitus en la atención primaria para quedar como Norma Oficial Mexicana NOM-015-SSA2-1994, Para la prevención, tratamiento y control de la diabetes. Diario Oficial de la Federación (DOF). 18 de enero del 2001. Primera secciónModification to the Official Mexican Norm NOM-015-SSA2-1994, For the prevention, treatment and control of the diabetes mellitus in the primary care to stay as Official Mexican Norm NOM-015-SSA2-1994, For the prevention, treatment and control of the diabetes. Official diary of the Federation (DOF). January 18, 2001. First section Available from: http://www.sideso.df.gob.mx/documentos/legislacion/NOM_015_SSA2.pdfAccessed December 6, 2011 Spanish
   Google Scholar
• GilLEDomínguezERSilMJParrillaJIde SantillanaSPTorresLPDiagnóstico y tratamiento de la diabetes mellitus tipo 2 en el primer nivel de atención. México, Instituto Mexicano del Seguro SocialDiagnosis and treatment of the diabetes mellitus type 2 in the primary attention levelMexicoMexican Social Security Institute2009 Spanish
   Google Scholar
• GonzálezCAValdezLACruzEADiagnóstico, metas de control ambulatorio y referencia oportuna de la diabetes mellitus tipo 2 en el primer nivel de atención. México, CENETEC-Secretaría de SaludDiagnosis, goals of outpatients control and opportune reference of the type 2 diabetes in the primary attention levelMexicoCENETEC-Ministry of Health2008 Spanish
   Google Scholar
• National Collaborating Centre for Chronic ConditionsType 2 diabetes: national clinical guideline for management in primary and secondary careLondonRoyal College of Physicians2008 Available from: http://www.nice.org.uk/nicemedia/pdf/CG66NICEGuideline.pdfAccessed December 6, 2011
   Google Scholar
• Grupo de trabajo de la Guía de Práctica Clínica sobre Diabetes tipo 2Guía de Práctica Clínica sobre Diabetes tipo 2. Madrid, Agencia de Evaluación de Tecnologías Sanitarias del País Vasco, 2008Workgroup of the Clinical Practice Guide on type 2 diabetes. Clinical Practice Guide on type 2 diabetesMadridEvaluation of Health Technologies Agency of the Basque Country2008 Available from: http://www.guiasalud.es/GPC/GPC_429_Diabetes_2_Osteba_compl.pdfAccessed December 6, 2011 Spanish
   Google Scholar
• PubMed.gov [database on the Internet]Bethesda, MDNational Center for Biotechnology Information, US Library of Medicinend Available from: http://www.ncbi.nlm.nih.gov/pubmed/Accessed December 6, 2011
   Google Scholar
• SciVerse Scopus [database on the Internet]AmsterdamElsevier2011 Available from: http://www.scopus.com/home.urlAccessed December 6, 2011
   Google Scholar
• The Cochrane Library [database on the Internet]Hoboken, NJJohn Wiley and Sons2010 Available from: http://www.thecochranelibrary.com/view/0/index.htmlAccessed December 6, 2011
   Google Scholar
• MEDLINE^® [database on the Internet]Bethesda, MDNational Library of Medicinend Available from: http://www.ncbi.nlm.nih.gov/pubmed/Accessed December 6, 2011
   Google Scholar
• Instituto Mexicano del Seguro Social (IMSS)Costos Unitarios por Nivel de Atención Médica para el ano 2009. Diario Oficial de la Federación (DOF). 6 de marzo del 2009Unitary costs for Medical Attention Level. Federal Official Daily Gazette (DOF)March 62009 Available from: http://www.consultoriofiscalunam.com.mx/seccion-6-6.html Spanish
   Google Scholar
• Instituto Mexicano del Seguro SocialPortal de Transparencia [Website of Transparent Information] Available from: http://transparencia.imss.gob.mx/Accessed June 23, 2009 Spanish
   Google Scholar
• Servicio de Administración Tributaria (SAT)Salarios Mínimos durante el 2009 [Minimum wages in 2009] Available from: http://www.sat.gob.mx/sitio_internet/asistencia_contribuyente/informacion_frecuente/salarios_minimos/45_13706.htmlAccessed March 23, 2011 Spanish
   Google Scholar
• DeFronzoRAGoodmanAMEfficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study GroupN Engl J Med199533395415497623902
   PubMed Web of Science ®Google Scholar
• Del PratoSErkelensDWLeuteneggerMSix-month efficacy of benfluorex vs placebo or metformin in diet-failed type 2 diabetic patientsActa Diabetol2003401202712682825
   PubMed Web of Science ®Google Scholar
• GarberAJLarsenJSchneiderSHPiperBAHenryDSimultaneous glibenclamide/metformin therapy is superior to component monotherapy as an initial pharmacological treatment for type 2 diabetesDiabetes Obes Metab20024320120812047399
   PubMed Web of Science ®Google Scholar
• HortonESClinkingbeardCGatlinMFoleyJMallowsSShenSNateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetesDiabetes Care200023111660166511092289
   PubMed Web of Science ®Google Scholar
• FischerSPatzakARietzschHInfluence of treatment with acarbose or glibenclamide on insulin sensitivity in type 2 diabetic patientsDiabetes Obes Metab200351384412542723
   PubMed Web of Science ®Google Scholar
• ChanJCChanKWHoLLAn Asian multicenter clinical trial to assess the efficacy and tolerability of acarbose compared with placebo in type 2 diabetic patients previously treated with diet. Asian Acarbose Study GroupDiabetes Care1998217105810619653595
   PubMed Web of Science ®Google Scholar
• MarreMHowlettHLehertPAllavoineTImproved glycaemic control with metforming libenclamide combined tablet therapy (Glucovance) in type 2 diabetic patients inadequately controlled on metforminDiabet Med200219867368012147149
   PubMed Web of Science ®Google Scholar
• BlondeLRosenstockJMooradianADPiperBAHenryDGlibenclamide/metformin combination product is safe and efficacious in patients with type 2 diabetes failing sulphonylurea therapyDiabetes Obes Metab20024636837512406033
   PubMed Web of Science ®Google Scholar
• SaenzAFernández-EstebanIMataixAAusejoMRoqueMMoherDMetformin monotherapy for type 2 diabetes mellitusCochrane Database Syst Rev20053CD00296616034881
   PubMed Web of Science ®Google Scholar
• Van de LaarFALucassenPLAkkermansRPVan de LisdonkEHRuttenGEVan WeelCAlpha-glucosidase inhibitors for type 2 diabetes mellitusCochrane Database Syst Rev20052CD00363915846673
   PubMed Web of Science ®Google Scholar
• SaenzAFernandez-EstebanIMataixAAusejo SeguraMRoqué i FigulsMMoherDMetformin monotherapy for type 2 diabetes mellitusCochrane Database Syst Rev20053CD00296616034881
   PubMed Web of Science ®Google Scholar
• SalpeterSRGreyberEPasternakGASalpeterEERisk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitusCochrane Database Syst Rev20104CD002967
   Web of Science ®Google Scholar